Prenetics Global is trading 5.55% down at $22.99 on September 22, 2026, apparently driven by trading-specific positioning or an undisclosed catalyst rather than broad market weakness.

  • Recent coverage highlights strong second-quarter revenue growth and raised full-year guidance.
  • The broader market is mixed: Nasdaq up 0.34% and Dow down 0.42%.
  • Volume and activity-level data were not provided.